Annji Pharmaceutical CoROCO:7754 +5.61%9 Gross Margin % is 65.87% as of Dec. 2025, which is 296% above its 10-year median of 16.64. GuruFocus rates ROCO:7754 with a GF Score™ of 9/100. The stock has 6 warning signs investors should review. Among 732 Biotechnology companies, Annji Pharmaceutical Co ranks worse than 87.3% on this metric.
ROCO:7754's Gross Margin % is ranked worse than 87.3% of 732
companies
in the Biotechnology industry
Industry Median: 60.91
vs ROCO:7754: 16.65
Annji Pharmaceutical Co had a gross margin of 65.87% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Annji Pharmaceutical Co was 0.00% per year.
Annji Pharmaceutical Co (ROCO:7754) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Annji Pharmaceutical Co had a gross margin of 65.87% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Annji Pharmaceutical Co Gross Margin % Related Terms
Annji Pharmaceutical Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7754 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Annji Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Annji Pharmaceutical Co Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Annji Pharmaceutical Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Annji Pharmaceutical Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Annji Pharmaceutical Co (ROCO:7754) has a Gross Margin % of 65.87% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Annji Pharmaceutical Co and its competitors. This is 296% above median its historical median of 16.64. Over the past decade, Annji Pharmaceutical Co's Gross Margin % has ranged from 9.22 to 68.57. According to the industry distribution chart, Annji Pharmaceutical Co ranks #639 out of 732 companies in the Biotechnology industry, placing it in the top 87.3%.
Is Annji Pharmaceutical Co's Gross Margin % too high?
Annji Pharmaceutical Co's current Gross Margin % of 65.87% is 296% above median its 10-year median of 16.64. Over the past 10 years, this metric has ranged from a low of 9.22 to a high of 68.57. The Biotechnology industry median Gross Margin % is 60.91. Annji Pharmaceutical Co's value of 65.87% is 8.1% above this industry median. Based on the distribution chart, Annji Pharmaceutical Co ranks #639 out of 732 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Annji Pharmaceutical Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Annji Pharmaceutical Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Annji Pharmaceutical Co ranks #639 out of 732 companies for Gross Margin %. This places Annji Pharmaceutical Co in the lower half of its industry. The industry median Gross Margin % is 60.91. Annji Pharmaceutical Co's value of 65.87% is 8.1% above this benchmark. Historically, Annji Pharmaceutical Co's own Gross Margin % has ranged from 9.22 to 68.57 over the past decade. While the company's 10-year median is 16.64 vs. the industry median of 60.91, Annji Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Annji Pharmaceutical Co's current Gross Margin % of 65.87% is 8.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Annji Pharmaceutical Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Annji Pharmaceutical Co's current Gross Margin % is 65.87%, which is 296% above median its own 10-year median of 16.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annji Pharmaceutical Co stock overvalued right now?
Annji Pharmaceutical Co (ROCO:7754) has a current Gross Margin % of 65.87%. The current Gross Margin % is 65.87%, which is 296% above median its 10-year median of 16.64 and 8.1% above the Biotechnology industry median of 60.91. Annji Pharmaceutical Co's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Annji Pharmaceutical Co (ROCO:7754), the current Gross Margin % is 65.87% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.
9GF Score
Get the complete analysis for ROCO:7754
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7754 has been successfully added to your 